Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP513474.RAW3gzQeV-mDo5ENIKtX3SMXo0IML40coLzH-1j3LCZ5w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP513474.RAW3gzQeV-mDo5ENIKtX3SMXo0IML40coLzH-1j3LCZ5w130_assertion type Assertion NP513474.RAW3gzQeV-mDo5ENIKtX3SMXo0IML40coLzH-1j3LCZ5w130_head.
- NP513474.RAW3gzQeV-mDo5ENIKtX3SMXo0IML40coLzH-1j3LCZ5w130_assertion description "[The group of patients with intermediate CYP2D6 metabolism (0.5 SGD) had a significantly higher frequency of remitters from major depressive disorder during the 8-week treatment (p = 0.0001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP513474.RAW3gzQeV-mDo5ENIKtX3SMXo0IML40coLzH-1j3LCZ5w130_provenance.
- NP513474.RAW3gzQeV-mDo5ENIKtX3SMXo0IML40coLzH-1j3LCZ5w130_assertion evidence source_evidence_literature NP513474.RAW3gzQeV-mDo5ENIKtX3SMXo0IML40coLzH-1j3LCZ5w130_provenance.
- NP513474.RAW3gzQeV-mDo5ENIKtX3SMXo0IML40coLzH-1j3LCZ5w130_assertion SIO_000772 20350136 NP513474.RAW3gzQeV-mDo5ENIKtX3SMXo0IML40coLzH-1j3LCZ5w130_provenance.
- NP513474.RAW3gzQeV-mDo5ENIKtX3SMXo0IML40coLzH-1j3LCZ5w130_assertion wasDerivedFrom befree-20140225 NP513474.RAW3gzQeV-mDo5ENIKtX3SMXo0IML40coLzH-1j3LCZ5w130_provenance.
- NP513474.RAW3gzQeV-mDo5ENIKtX3SMXo0IML40coLzH-1j3LCZ5w130_assertion wasGeneratedBy ECO_0000203 NP513474.RAW3gzQeV-mDo5ENIKtX3SMXo0IML40coLzH-1j3LCZ5w130_provenance.